High rate of seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine in Iranian healthy nonresponder neonates

Medical Microbiology and Immunology

Volumn 185, Issue 4, 1997, Pages 231-235

  Shokri, Fazel ^a,b   Amani, Abdollah ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Blood Transfusion Center of Sanandaj   (Iran)

Author keywords

Antibody to hepatitis b surface antigen; Hepatitis b virus; Seroconversion; Vaccination

Indexed keywords

EID: 0030418407     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004300050035     Document Type: Article

References (27)

1. Mackett M, Williamson JD (1995) Human vaccines and vaccination. Bios Scientific, Oxford, pp 159-176
2. Kurstak E (1993) Viral hepatitis. Springer, Wien New York, pp 83-90
3. Tsega E, Tsega M, Mengesha B, Nordenfeit E, Hansson BG, Lindberg J (1988) Transmission of HBV infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol 17:874-879
4. Ghendon Y (1987) Perinatal Transmission of HBV in high incidence countries. J Virol Methods 17:69-79
5. Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60
6. Amini S, Mahmoodi M ( 1993) Seroepidemiology of hepatitis B, Delta and HIV infections in Hamadan province of Iran. J Trop Med Hyg 96:277-287
7. World Health Organization (1992) Expanded Program on Immunization, Global Advisory Group. Wkly Epidemiol Rec 3:11-16
8. Amani A, Shokri F (1995) Immunogenecity of a recombinant hepatitis B vaccine in Iranian neonates: high frequency of unresponsiveness independent of the carrier state of mothers. Ir J Med Sei 20:87-92
9. Weissman JY, Tsuchiyose MM, Tong MJ, et al. (1988) Lack of response to recombinant hepatitis B vaccine in non-responders to the plasma vaccine. JAMA 260:1734-1738
10. Craven DE, Awdeh ZL, Kunches LM, et al. (1986) Non-responsiveness to hepatitis B vaccine in health care workers: results of revaccination and genetic typings. Ann Intern Med 105:356-360
11. Rogan PD, Duguid KM (1991) Immunization of staff of a regional blood transfusion center with a recombinant hepatitis B vaccine. J Infect 22:5-9
12. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O (1994) Seroconversion after additional vaccine doses to nonresponders to three doses of intradermally and intramuscularly administered recombinant hepatitis B vaccine. Scand J Infect Dis 26:468-470
13. Cheng KF, Chang MH, Lee CY, et al. (1994) Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in healthy non-responding children. Vaccine 12:899-902
14. Tan KL, Goh KT, Don CJ, Chan SH (1994) Immunogenicity of recombinant yeast-derived hepatitis B vaccine in non-responders to perinatal immunization. JAMA 271:859-861
15. Hatae K, Kimura A, Okubo R, et al. (1992) Genetic control of non-responsiveness to hepatitis B virus vaccine by an extended HLA haplotype. Eur J Immunol 22:1899-1905
16. Martinetti M, Cuccia M, Daielli C, et al. ( 1995) Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity. Vaccine 13:555-560
17. Alper CA, Kruskall MS, Marcus-Bagley D, et al. (1989) Genetic prediction of non-response to hepatitis B vaccine. N Engl J Med 321:708-712
18. Desombere I, Hauser P, Rossau R, Paradijs J, Roels GL (1995) Non-responders to hepatitis B vaccine can present envelope particles to T lymphocytes. J Immunol 154:520-529
19. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A ( 1990) Is a function of the secreted HBe antigen to induce immunological tolerance in utero. Proc Natl Acad Sei USA 87:6599-6603
20. Watanabe H, Okumura M, Hirayama K, Sasazuki T ( 1990) HLABw54-DR4-DRw53 haplotype controls non-responsiveness to hepatitis B surface antigen via CD8-positive suppressor T cells. Tissue Antigens 36:69-74
21. Wands JR, Liang TJ, Blum HE, Shafritz DA (1992) Molecular pathogenesis of liver disease during persistent hepatitis B virus infection. Semin Liver Dis 12:252-264
22. Badur S, Lazizi Y, Ugurlu M, Perk Y. Aydinli K, Pillot J (1994) Transplacental passage of HBV DNA from HBe antigen-negative mothers and delayed immune response in newborns. J Infect Dis 169:704-706
23. Ridge JP, Fuchs EJ, Matzinger P (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726
24. Forsthuber T, Yip HC, Lehmann PV (1996) Induction of Thl and Th2 immunity in neonatal mice. Science 271:1728-1730
25. Trivello R, Chiaramonte M, Ngatchu T, et al. (1995) Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNAHB booster vaccine. Vaccine 13:139-141
26. Kooten CV, Banchereau J (1996) CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 61:1-77
27. Jug W, Schmidt M, Deinhardt F, Zachoval R (1984) Hepatitis B vaccination: how long does protection last? Lancet 11:458